Skip to main content
. 2016 Mar 26;7(16):22960–22969. doi: 10.18632/oncotarget.8392

Figure 5. The lifetime attributable risk of secondary malignancy in each organ at risk for the five treatment modalities.

Figure 5

a. Ipsilateral lung, contralateral lung, contralateral breast, and thyroid. b. Liver, stomach, colon, gonad, and rectum.